While GLP-1s are not magic, they often help the body act more like its younger self
Key Takeaways on Wegovy Insurance Coverage FDA-approved for weight management : Wegovy (semaglutide 2.4mg) is approved for chronic weight management in adults with BMI 30, or BMI 27 with at least one weight-related comorbidity Commercial insurance coverage is expanding : About 40-50% of employer-sponsored plans now cover GLP-1 medications for weight loss, up from under 20% in 2023 Medicare does NOT cover Wegovy for weight loss : Federal law prohibits Medicare Part D from covering drugs prescribed solely for weight management no exceptions List price without insurance : Approximately $1,349/month ($16,188/year) at retail pharmacy Savings programs available : Novo Nordisk offers a savings card reducing cost to as low as $0-$25/month for eligible commercially insured patients Wegovy is a once-weekly injectable prescription medication containing semaglutide at the 2.4mg dose, manufactured by Novo Nordisk

(2006) was calculated according to the Cochrane Handbook for Systematic Reviews of Interventions section 6.5.2.3(3) (Higgins et al
The treatment lowers blood sugar levels making it ideal for individuals who are prediabetic or have type 2 diabetes
These criteria are guidelines, and only an Ozempic lawyer can tell you if you qualify to file a lawsuit
Understanding these differences supports informed conversations with providers about which approach may align with individual health objectives and baseline antioxidant status